-PTI Geneva: Ruling against India, the WTO today said the government’s power purchase agreements with solar firms were “inconsistent” with international norms — a matter in which the US had filed a complaint before the global trade body, alleging discrimination against American firms. The US had dragged India to the WTO on this issue in 2014, alleging that the clause relating to domestic content requirement (DCR) in the country’s solar power mission...
More »SEARCH RESULT
India must call the US' bluff on patents-Arvind Panagariya
-The Business Standard The recent US-India friction over trade is being driven by Big Pharma Apart from the deterioration of the business environment generally, which impacts both domestic and foreign investors, retrospective taxation has figured most prominently in the media as the principal cause of growing scepticism among foreign investors. Entirely missing from the discourse has been an equally potent factor with wholly foreign origins: the hijacking of the economic policy...
More »A pound of flesh to feed the poor-Arun Mohan Sukumar
-The Hindu Realising that New Delhi needs to clear its food security legislation at the WTO in time for the election, the West has sought increased market access in return for temporary relief A few months ago, the most optimistic observers of international politics were not willing to hedge their bets on the Doha Development Round at the World Trade Organisation. The Doha Round negotiations have been stalled for more than a...
More »The shaky geopolitics of India’s food security-Arun Mohan Sukumar
-The Hindu The UPA seems to have forgotten that the country's trade commitments, including to the WTO, stand in the way of its implementing the Food Security Ordinance The last time I began an essay with the words "in this era of globalisation," in high school, even my teacher winced at the cliché. In junking the phrase, however, we may have forgotten its import too. The United Progressive Alliance (UPA) certainly seems...
More »Strong medicine for poor countries-Nayanima Basu
-The Business Standard The Novartis verdict by the Supreme Court emphasised the importance of flexibilities in drug patent laws, in contrast to Western countries which are seeking TRIPS-plus hardening through free-trade agreements As curtains on the six-year-long legal tussle with Swiss drug giant Novartis AG finally came down earlier this month, the Indian government did not waste a second in hailing the Indian patent law which it said was in "full...
More »